Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial
Background: Hydroxychloroquine (HCQ) has proved ineffective in treating patients hospitalised with Coronavirus Disease 2019 (COVID-19), but uncertainty remains over its safety and efficacy in chemoprevention. Previous chemoprevention randomised controlled trials (RCTs) did not individually show bene...
Hlavní autoři: | Schilling, WHK, Mukaka, M, Callery, JJ, Llewelyn, MJ, Cruz, CV, Dhorda, M, Ngernseng, T, Waithira, N, Ekkapongpisit, M, Watson, JA, Chandna, A, Nelwan, EJ, Hamers, RL, Etyang, A, Beg, MA, Sow, S, Yavo, W, Allabi, AC, Basnyat, B, Sharma, SK, Amofa-Sekyi, M, Yonga, P, Adler, A, Yuentrakul, P, Abdad, MY, Blacksell, SD, Tarning, J, Rahardjani, M, Rimainar, A, Akech, S, Hamaluba, M, Shrestha, S, Rijal, S, Woodrow, CJ, Cheah, PY, Taylor, WRJ, Batty, EM, von Seidlein, L, Dondorp, A, Day, NPJ, White, NJ |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Public Library of Science
2024
|
Podobné jednotky
-
Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; protocol for a randomised, placebo-controlled prophylaxis study (COPCOV)
Autor: Schilling, WHK, a další
Vydáno: (2020) -
The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions
Autor: Schilling, WHK, a další
Vydáno: (2021) -
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Autor: Luvira, V, a další
Vydáno: (2024) -
Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)
Autor: Schilling, WHK, a další
Vydáno: (2023) -
Clinical antiviral efficacy of remdesivir in coronavirus disease 2019: an open-label, randomized controlled adaptive platform trial (PLATCOV)
Autor: Jittamala, P, a další
Vydáno: (2023)